학술논문
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
Document Type
Artikel
Author
Source
The Lancet. Neurology. 17(12):1053-1060
Subject
Language
English
English
English
ISSN
1474-4465